In our study, this depended on the format of the IgM method used: in particular, 62% (28/45) of women were still CLIA IgM-positive beyond 180 days after onset of infection, whereas only 13% (6/45) were ELISA IgM-positive. The gene discussed is CD40LG; the disease is infection.